Clinical Trials Browser

Glioma × Granulocyte Colony-Stimulating Factor × 1 year × Clear all

NCT06528691 2026-05-13

Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors

Phase 2 Recruiting

Glioma, Central Nervous System Neoplasms